Fabienne Hermitte
General Counsel bei VERACYTE, INC.
Aktive Positionen von Fabienne Hermitte
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VERACYTE, INC. | General Counsel | 01.08.2021 | - |
Karriereverlauf von Fabienne Hermitte
Ehemalige bekannte Positionen von Fabienne Hermitte
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
HalioDx SASU
HalioDx SASU BiotechnologyHealth Technology Part of HalioDxinvest SAS, HalioDx SASU is a French company that offers a comprehensive suite of biomarker services to deliver integrated and interpreted data, uncovering the critical biomarkers that drive effective decision-making. The private company is based in Marseille, France. The company's services include outsourcing assays such as NGS, qPCR, ELISA, IHC, and IVD testing to Veracyte. The company also offers Immunogram, a service that integrates multi-omic data sets into a single per patient view of key biomarker signatures specific to their own TME. Additionally, Veracyte, a unique multiplex tissue imaging and analysis approach, combines multiple technologies to characterize the tumor microenvironment. The company was founded in 2014 by Vincent Fert, who has been the CEO since 2014. | Gründer | 01.01.2015 | 01.08.2021 |
QIAGEN MARSEILLE | Technik-/Wissenschafts-/F&E-Leiter | 23.09.1999 | - |
Gründer | 07.07.2010 | - | |
General Counsel | 23.09.1999 | - |
Ausbildung von Fabienne Hermitte
Institut de Formation Supérieure BioMédicale | Undergraduate Degree |
AgroParisTech | Doctorate Degree |
Faculté de Médecine Paris | Graduate Degree |
Statistik
International
Frankreich | 6 |
Vereinigte Staaten | 2 |
Operativ
Founder | 2 |
General Counsel | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VERACYTE, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
QIAGEN Marseille SA
QIAGEN Marseille SA Miscellaneous Commercial ServicesCommercial Services QIAGEN Marseille SA is a molecular diagnosis company, which focuses on the development and marketing of diagnostic tests in the field of oncology. Its products are used for diagnosis, prognosis and monitoring of patients with leukemia. The company was founded by Vincent Fert, Stéphane Debono, and Fabienne Hermitte on September 23, 1999 and is headquartered in Marseille, France. | Commercial Services |
HalioDx SASU
HalioDx SASU BiotechnologyHealth Technology Part of HalioDxinvest SAS, HalioDx SASU is a French company that offers a comprehensive suite of biomarker services to deliver integrated and interpreted data, uncovering the critical biomarkers that drive effective decision-making. The private company is based in Marseille, France. The company's services include outsourcing assays such as NGS, qPCR, ELISA, IHC, and IVD testing to Veracyte. The company also offers Immunogram, a service that integrates multi-omic data sets into a single per patient view of key biomarker signatures specific to their own TME. Additionally, Veracyte, a unique multiplex tissue imaging and analysis approach, combines multiple technologies to characterize the tumor microenvironment. The company was founded in 2014 by Vincent Fert, who has been the CEO since 2014. | Health Technology |
- Börse
- Insiders
- Fabienne Hermitte
- Erfahrung